蓝帆转债：董事会提议下修 力合微：股东拟减持不超3%公司股份 万孚转债：不下修 应流转债：【上市】 丹娜生物：北交所新股【申购】 | 转债代码 | 转债名称 | 类型 | 日期 | 公告 | | --- | --- | --- | --- | --- | | 128108 | 蓝帆转债 | 提议下修 | 2025-10-22 | 公告 | | 123064 | 万孚转债 | 不下修 | 2025-10-21 | 公告 | | 转债代码 | 转债名称 | 现价 | 赎回价 | 最后交易日 | 最后转股日 | 转股价值 | 剩余规模 | 转债占正股 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (税前) | | | | (亿元) | 流通市值比 | | 110059 | 浦发转债 | 110.850 | 110.000 | 2025-10-22 | 2025-10-27 | 103.84 | 30.947 | 0.73% | | 110060 | 天路转债 | 293.269 | 110.000 | 2025-10-22 | 2 ...

证券日报网讯10月21日晚间，万孚生物（300482）发布公告称，公司于2025年10月21日召开第五届董事 会第十五次会议，审议通过了《关于不向下修正可转换公司债券转股价格的议案》，公司董事会决定本 次不向下修正"万孚转债"转股价格，且自董事会审议通过次一交易日起未来三个月内(即2025年10月22 日至2026年1月21日)，如再次触发"万孚转债"转股价格向下修正条款，亦不提出向下修正方案。自2026 年1月22日起算，若再次触发"万孚转债"转股价格的向下修正条款，届时公司董事会将再次召开会议决 定是否行使"万孚转债"转股价格的向下修正权利。 ...

Core Viewpoint - The company announced that its stock price has been below 80% of the current conversion price for 10 trading days, which may trigger a downward adjustment of the conversion price for its convertible bonds [1] Group 1 - The stock price of Guangzhou Wanfu Biological Technology Co., Ltd. has been below the conversion price of 21.60 yuan per share since September 19, 2025 [1] - The company will hold a board meeting to decide whether to adjust the conversion price if the conditions for adjustment are triggered [1] - The company commits to timely information disclosure following the board's decision [1]

Key Points - The company, Wondfo Biotech, will distribute interest for its convertible bonds, with a payment of 18.00 RMB (including tax) for every 10 bonds held [1][2] - The interest payment period is from September 1, 2024, to August 30, 2025, with a coupon rate of 1.80% [2] - Holders of the convertible bonds must apply for conversion into company stock by August 29, 2025, to forgo interest payments for the current and subsequent periods [1][4] - The company has a long-term credit rating of AA, and the convertible bonds also hold an AA rating with a stable outlook [2] - The interest income tax for individual bondholders is set at a rate of 20%, which will be withheld by the payment agents [4][6] - Foreign institutional investors are exempt from corporate income tax and value-added tax on interest income from these bonds until December 31, 2025 [5]